SCI Pharmtech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4119?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,984,2911.66%
Employee Share Scheme3,083,4472.58%
Institutions4,570,7603.82%
Individual Insiders7,866,7266.58%
Public Companies37,907,94731.7%
General Public64,095,46353.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.2%.


Top Shareholders

Top 16 shareholders own 46.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.7%
Mercuries & Associates Holding, Ltd.
37,907,947NT$3.4b0%no data
5.64%
Li-Wei Zhan
6,738,000NT$603.1m0%no data
2.58%
SCI Pharmtech, Inc., ESOP
3,083,447NT$276.0m6.54%no data
1.45%
Fubon Life Insurance Co., Ltd., Asset Management Arm
1,738,125NT$155.6m0%0.03%
1.06%
Shuren Investment Co., Ltd.
1,270,125NT$113.7m0%no data
1.04%
UBS Asset Management AG
1,248,218NT$111.7m0%no data
0.85%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,010,250NT$90.4m0%no data
0.62%
Wei-Chyun Wong
739,389NT$66.2m0%no data
0.6%
Shanglin Investment Co., Ltd.
714,166NT$63.9m8.93%no data
0.44%
Dimensional Fund Advisors LP
531,010NT$47.5m12.6%no data
0.17%
Wen-Chih Chou
205,781NT$18.4m0%no data
0.093%
Jun-Bang Ye
111,499NT$10.0m0%no data
0.045%
Wang Vincent
54,164NT$4.8m0%no data
0.036%
State Street Global Advisors, Inc.
43,157NT$3.9m0%no data
0.011%
Michele Seah
12,893NT$1.2m-48.2%no data
0.0042%
Ching-Hsin Hsu
5,000NT$447.1k0%no data